AmirAli Talasaz Ph.D.
Net Worth

Last updated:

What is AmirAli Talasaz Ph.D. net worth?

The estimated net worth of Dr. AmirAli Talasaz Ph.D. is at least $415,467,081 as of 30 Sep 2024. He owns shares worth $1,419,353 as insider, has earned $412,309,408 from insider trading and has received compensation worth at least $1,738,320 in Guardant Health, Inc..

What is the salary of AmirAli Talasaz Ph.D.?

Dr. AmirAli Talasaz Ph.D. salary is $289,720 per year as Co-Chief Executive Officer & Director in Guardant Health, Inc..

How old is AmirAli Talasaz Ph.D.?

Dr. AmirAli Talasaz Ph.D. is 46 years old, born in 1979.

What stocks does AmirAli Talasaz Ph.D. currently own?

As insider, Dr. AmirAli Talasaz Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Guardant Health, Inc. (GH) Co-Chief Executive Officer & Director 24,250 $58.53 $1,419,353

What does Guardant Health, Inc. do?

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

AmirAli Talasaz Ph.D. insider trading

Guardant Health, Inc.

Dr. AmirAli Talasaz Ph.D. has made 57 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 565,192 units of GH stock on 1 Jan 2021. As of 30 Sep 2024 he still owns at least 24,250 units of GH stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 11,461 N/A N/A
Option
Common Stock 11,461 N/A N/A
Option
Restricted Stock Units 11,462 N/A N/A
Option
Common Stock 11,462 N/A N/A
Option
Stock Option (Right to Buy) 283,830 $4.18 $1,186,409
Option
Common Stock 283,830 $4.18 $1,186,409
Option
Restricted Stock Units 11,461 N/A N/A
Option
Common Stock 11,461 N/A N/A
Purchase
COMMON STOCK 8,500 $26.4 $224,375
Purchase
COMMON STOCK 4,250 $26.4 $112,187
Purchase
COMMON STOCK 27,813 $26.04 $724,223
Purchase
COMMON STOCK 12,187 $24.78 $301,994
Purchase
COMMON STOCK 13,906 $26.04 $362,098
Purchase
COMMON STOCK 6,094 $24.78 $151,009
Purchase
COMMON STOCK 54,500 $94.97 $5,175,702
Purchase
COMMON STOCK 50,000 $98.3 $4,915,200
Option
COMMON STOCK 23,923 $4.18 $99,998
Option
STOCK OPTION (RIGHT TO BUY) 23,923 $4.18 $99,998
Sale
COMMON STOCK 232,393 $94.66 $21,998,786
Sale
COMMON STOCK 232,393 $130.94 $30,430,469
Sale
COMMON STOCK 66,993 $79.61 $5,333,514
Sale
COMMON STOCK 66,993 $160.01 $10,719,684
Sale
COMMON STOCK 116,180 $101.86 $11,834,095
Sale
COMMON STOCK 116,180 $81.62 $9,482,147
Sale
COMMON STOCK 116,180 $163.23 $18,964,061
Sale
COMMON STOCK 106,525 $101.63 $10,826,136
Sale
COMMON STOCK 231,945 $133.43 $30,947,957
Sale
COMMON STOCK 87,200 $130.19 $11,352,132
Sale
COMMON STOCK 88,377 $158.74 $14,028,700
Sale
COMMON STOCK 150,391 $157.75 $23,724,331
Sale
COMMON STOCK 110,013 $154.56 $17,003,389
Option
Performance-Based Restricted Stock Units 565,192 N/A N/A
Option
COMMON STOCK 565,192 N/A N/A
Option
STOCK OPTION (RIGHT TO BUY) 23,923 $4.18 $99,998
Option
COMMON STOCK 23,923 $4.18 $99,998
Sale
COMMON STOCK 75,851 $107.78 $8,174,917
Sale
COMMON STOCK 4,613 $105.02 $484,471
Sale
COMMON STOCK 13,136 $105.16 $1,381,316
Sale
COMMON STOCK 23,400 $102.72 $2,403,531
Sale
COMMON STOCK 75,000 $110.77 $8,307,675
Sale
COMMON STOCK 75,000 $94.12 $7,059,225
Option
STOCK OPTION (RIGHT TO BUY) 15,000 $4.18 $62,700
Option
COMMON STOCK 15,000 $4.18 $62,700
Sale
COMMON STOCK 15,000 $84.8 $1,271,955
Option
COMMON STOCK 60,000 $4.18 $250,800
Sale
COMMON STOCK 60,000 $86.09 $5,165,280
Option
STOCK OPTION (RIGHT TO BUY) 60,000 $4.18 $250,800
Option
STOCK OPTION (RIGHT TO BUY) 20,108 $4.18 $84,051
Option
COMMON STOCK 20,108 $4.18 $84,051
Sale
COMMON STOCK 20,108 $84.2 $1,693,013
Sale
COMMON STOCK 54,892 $84.07 $4,614,990
Option
STOCK OPTION (RIGHT TO BUY) 54,892 $4.18 $229,449
Option
COMMON STOCK 54,892 $4.18 $229,449
Option
STOCK OPTION (RIGHT TO BUY) 55,000 $4.18 $229,900
Option
COMMON STOCK 55,000 $4.18 $229,900
Sale
COMMON STOCK 55,000 $86.42 $4,752,825
Option
COMMON STOCK 20,000 $4.18 $83,600
Sale
COMMON STOCK 20,000 $88.25 $1,765,000
Option
STOCK OPTION (RIGHT TO BUY) 20,000 $4.18 $83,600
Option
COMMON STOCK 6,000 $4.18 $25,080
Sale
COMMON STOCK 199,951 $92.23 $18,441,881
Option
STOCK OPTION (RIGHT TO BUY) 6,000 $4.18 $25,080
Sale
COMMON STOCK 25,049 $90.13 $2,257,641
Option
COMMON STOCK 750 $4.18 $3,135
Option
STOCK OPTION (RIGHT TO BUY) 750 $4.18 $3,135
Option
STOCK OPTION (RIGHT TO BUY) 1,762 $4.18 $7,365
Sale
COMMON STOCK 73,413 $83.1 $6,100,620
Sale
COMMON STOCK 68,013 $83.53 $5,680,854
Option
COMMON STOCK 1,762 $4.18 $7,365
Option
STOCK OPTION (RIGHT TO BUY) 2,400 $4.18 $10,032
Sale
COMMON STOCK 100,000 $81.31 $8,131,100
Option
COMMON STOCK 2,400 $4.18 $10,032
Sale
COMMON STOCK 20,877 $79.22 $1,653,876
Sale
COMMON STOCK 31,183 $77.61 $2,420,113
Option
COMMON STOCK 2,800 $4.18 $11,704
Option
STOCK OPTION (RIGHT TO BUY) 2,800 $4.18 $11,704
Option
COMMON STOCK 13,435 $4.18 $56,158
Option
STOCK OPTION (RIGHT TO BUY) 13,435 $4.18 $56,158
Sale
COMMON STOCK 63,971 $73.31 $4,689,586
Sale
COMMON STOCK 43,351 $80.73 $3,499,596
Option
STOCK OPTION (RIGHT TO BUY) 1,040 $4.18 $4,347
Option
COMMON STOCK 1,040 $4.18 $4,347
Option
COMMON STOCK 314 $4.18 $1,313
Sale
COMMON STOCK 13,082 $80.23 $1,049,569
Option
STOCK OPTION (RIGHT TO BUY) 314 $4.18 $1,313
Option
COMMON STOCK 2,729 $4.18 $11,407
Sale
COMMON STOCK 12,999 $72.83 $946,743
Option
STOCK OPTION (RIGHT TO BUY) 2,729 $4.18 $11,407
Option
COMMON STOCK 7,771 $4.18 $32,483
Option
STOCK OPTION (RIGHT TO BUY) 7,771 $4.18 $32,483
Sale
COMMON STOCK 37,001 $72.91 $2,697,780
Option
STOCK OPTION (RIGHT TO BUY) 5,250 $4.18 $21,945
Sale
COMMON STOCK 25,000 $66.76 $1,668,975
Option
COMMON STOCK 5,250 $4.18 $21,945
Option
COMMON STOCK 6,324 $4.18 $26,434
Sale
COMMON STOCK 24,740 $82.77 $2,047,680
Option
STOCK OPTION (RIGHT TO BUY) 6,324 $4.18 $26,434
Option
COMMON STOCK 61,964 $4.18 $259,010
Option
STOCK OPTION (RIGHT TO BUY) 61,964 $4.18 $259,010
Sale
COMMON STOCK 242,410 $80.76 $19,577,759
Option
STOCK OPTION (RIGHT TO BUY) 201 $4.18 $840
Sale
COMMON STOCK 785 $80 $62,800
Option
COMMON STOCK 201 $4.18 $840
Sale
COMMON STOCK 4,126 $80.19 $330,864
Option
STOCK OPTION (RIGHT TO BUY) 1,054 $4.18 $4,406
Option
COMMON STOCK 1,054 $4.18 $4,406
Option
STOCK OPTION (RIGHT TO BUY) 11,277 $4.18 $47,138
Option
COMMON STOCK 11,277 $4.18 $47,138
Sale
COMMON STOCK 44,972 $80.19 $3,606,305
Option
STOCK OPTION (RIGHT TO BUY) 492 $4.18 $2,057
Option
COMMON STOCK 492 $4.18 $2,057
Sale
COMMON STOCK 1,962 $80.15 $157,254
Option
COMMON STOCK 17,231 $4.18 $72,026
Option
STOCK OPTION (RIGHT TO BUY) 17,231 $4.18 $72,026
Sale
COMMON STOCK 67,410 $79.21 $5,339,681
Option
COMMON STOCK 26,782 $4.18 $111,949
Sale
COMMON STOCK 104,774 $78.16 $8,189,450
Option
STOCK OPTION (RIGHT TO BUY) 26,782 $4.18 $111,949
Option
STOCK OPTION (RIGHT TO BUY) 71,769 $4.18 $299,994
Option
COMMON STOCK 71,769 $4.18 $299,994
Option
COMMON STOCK 4,721 $4.18 $19,734
Option
STOCK OPTION (RIGHT TO BUY) 4,721 $4.18 $19,734
Sale
COMMON STOCK 18,463 $93.6 $1,728,044
Option
STOCK OPTION (RIGHT TO BUY) 8,865 $4.18 $37,056
Sale
COMMON STOCK 35,031 $96.94 $3,395,905
Option
COMMON STOCK 8,865 $4.18 $37,056
Sale
COMMON STOCK 45,480 $98.94 $4,499,791
Option
STOCK OPTION (RIGHT TO BUY) 11,489 $4.18 $48,024
Option
COMMON STOCK 11,489 $4.18 $48,024
Option
STOCK OPTION (RIGHT TO BUY) 18,726 $4.18 $78,275
Option
COMMON STOCK 18,726 $4.18 $78,275
Sale
COMMON STOCK 73,253 $100.64 $7,372,035
Option
STOCK OPTION (RIGHT TO BUY) 6,349 $4.18 $26,539
Option
COMMON STOCK 6,349 $4.18 $26,539
Sale
COMMON STOCK 24,842 $98.42 $2,444,999
Option
COMMON STOCK 7,454 $4.18 $31,158
Option
STOCK OPTION (RIGHT TO BUY) 7,454 $4.18 $31,158
Sale
COMMON STOCK 37,896 $66.15 $2,506,934
Sale
COMMON STOCK 3,240 $67.63 $219,121
Sale
COMMON STOCK 77,734 $66.86 $5,197,451
Sale
COMMON STOCK 36,009 $66.86 $2,407,490
Sale
COMMON STOCK 75,037 $66.94 $5,023,127
Option
COMMON STOCK 15,202 $4.18 $63,544
Option
STOCK OPTION (RIGHT TO BUY) 15,202 $4.18 $63,544
Sale
COMMON STOCK 230,674 $66.09 $15,244,783
Option
STOCK OPTION (RIGHT TO BUY) 44,426 $4.18 $185,701
Option
COMMON STOCK 44,426 $4.18 $185,701

Guardant Health key executives

Guardant Health, Inc. executives and other stock owners filed with the SEC: